Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Cancer”

4,738 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,738 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)Looking for participantsNCT05844046
What this trial is testing

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Enrico De Toni 83
Not applicableNot Yet RecruitingNCT07618546
What this trial is testing

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 208
Testing effectiveness (Phase 2)Study completedNCT02745483
What this trial is testing

Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up Study

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 153
Testing effectiveness (Phase 2)Study completedNCT02400788
What this trial is testing

Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Yakult Honsha Co., LTD 179
Not applicableStudy completedNCT06416683
What this trial is testing

Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen)

Who this might be right for
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
University Hospital, Caen 109
Early research (Phase 1)Study completedNCT03418922
What this trial is testing

Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Eisai Co., Ltd. 30
Not applicableStudy completedNCT06960031
What this trial is testing

Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation

Who this might be right for
PET/CTHepatocellular MalignancyRadiofrequency Ablation
Tanta University 70
Not applicableWithdrawnNCT01659346
What this trial is testing

Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Thrombosis
Institute of Liver and Biliary Sciences, India
Not applicableLooking for participantsNCT06689670
What this trial is testing

Needle-based Percutaneous Ablation of Liver Tumors.

Who this might be right for
Liver TumorsHCC - Hepatocellular CarcinomaMetastatic Liver Tumor
inTumo Therapeutics, Inc. 31
Early research (Phase 1)Not Yet RecruitingNCT07077369
What this trial is testing

WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT00319683
What this trial is testing

ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Adherex Technologies, Inc.
Not applicableStudy completedNCT03317483
What this trial is testing

DEB-TACE Treatment in 367 Liver Cancer Patients

Who this might be right for
Liver Cancer
Zhejiang Cancer Hospital 367
Early research (Phase 1)UnknownNCT05353894
What this trial is testing

Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers

Who this might be right for
Primary Liver Cancer
Genoscience Pharma 27
Not applicableStudy completedNCT06086002
What this trial is testing

Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 20
Large-scale testing (Phase 3)Study completedNCT01229839
What this trial is testing

Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 668
Testing effectiveness (Phase 2)UnknownNCT03116945
What this trial is testing

Novel Gallium Imaging in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Rutgers, The State University of New Jersey 18
Not applicableUnknownNCT05609695
What this trial is testing

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Early research (Phase 1)Study completedNCT02686372
What this trial is testing

TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 13
Next Page